LATIN AMERICA BOTULINUM TOXIN MARKET 2021-2028

Lifesciences | Healthcare & Wellness

LATIN AMERICA BOTULINUM TOXIN MARKET 2021-2028

Market by Type, Application, End-user, and Country Outlook | Forecast 2021-2028

Request For Customization

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

According to Triton Market Research, the botulinum toxin market in Latin America is poised to proliferate with a CAGR of 5.48% over the forecasting phase from 2021 to 2028.


Report scope can be customized per your requirements. Request For Customization

The countries considered in this region are:

•           Brazil

•           Mexico

•           Rest of Latin America countries

In Brazil, the rising adoption of minimally invasive & non-invasive cosmetic procedures and the broad range of indications with respect to botulinum toxin-based treatment are the major market drivers. The brand names of botulinum toxin type A formulations available in Brazil include Botox, Xeomin, Dysport, Botulift, and Prosigne. The ISAPS has stated that, botulinum toxin-based treatment was the most common non-surgical procedure performed in the country in 2018, procedures accounting for 51% (approx. 392,530) of the total non-surgical procedures that year. Moreover, Brazil is the second-most-popular country in the world, in terms of botulinum toxin-based aesthetic procedures performed. All these factors have enhanced the adoption of botulinum toxin-based aesthetic procedures.

In addition, the entry of key players in the Brazilian market is expected to significantly impact the growth prospects. For instance, Daewoong Pharmaceutical, in February 2020, received approval from ANVISA for the usage and sale of the botulinum toxin type, Nabota, in Brazil. Therefore, given the rising demand for botulinum toxin-based non-invasive procedures and the introduction of botulinum toxin-based products by reputed industry players are expected to foster the growth of the over the botulinum toxin market forecast period.

Hugel Inc. is one of the most prominent names in the aesthetics & therapeutics market. The company is engaged in developing, manufacturing, and marketing biomedical products. It is one of the global experts in the field of medical aesthetic solutions, with products such as botulinum toxins, clinical derma cosmetics, HA fillers, and others. The company’s subsidiaries include Hugel America Inc, Across Co Ltd, Croma Aesthetics Canada Ltd, Croma Australia Pty Ltd, Weihai Hugel Pharma Co Ltd, and Hugel Pharma (Vietnam) Co Ltd. Hugel has a global network, with partners spread across more than 40 countries. The company’s botulinum toxin is marketed in 27 countries, including Brazil, Chile, Colombia, Panama, Ecuador, Peru, Uruguay, Bolivia, Paraguay, Honduras, Costa Rica, El Salvador, Guatemala, and the Dominican Republic.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. LATIN AMERICA BOTULINUM TOXIN MARKET – SUMMARY   

2. INDUSTRY OUTLOOK  

2.1. KEY INSIGHTS      

2.1.1. SURGE IN DISPOSABLE INCOME         

2.1.2. GROWING NUMBER OF MEN OPTING FOR COSMETIC TREATMENT   

2.1.3. DEVELOPMENT OF HEALTHCARE INFRASTRUCTURE    

2.2. IMPACT OF COVID-19 ON THE BOTULINUM TOXIN INDUSTRY

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1. THREAT OF NEW ENTRANTS    

2.3.2. THREAT OF SUBSTITUTE

2.3.3. BARGAINING POWER OF SUPPLIERS

2.3.4. BARGAINING POWER OF BUYERS      

2.3.5. THREAT OF COMPETITIVE RIVALRY  

2.4. MARKET ATTRACTIVENESS MATRIX

2.5. VENDOR SCORECARD 

2.6. KEY MARKET STRATEGIES     

2.6.1. NEW PRODUCT LAUNCHES      

2.7. MARKET DRIVERS         

2.7.1. INCREASING DEMAND FOR AESTHETIC PROCEDURES 

2.7.2. EXPANSION OF BOTULINUM TOXIN INTO THERAPEUTIC APPLICATIONS     

2.8. MARKET RESTRAINTS  

2.8.1. ADVERSE EFFECTS ASSOCIATED WITH BOTULINUM TOXIN     

2.8.2. LACK OF REIMBURSEMENT POLICIES SUPPORTING COSMETIC PROCEDURES   

2.8.3. LACK OF INTERCHANGEABILITY BETWEEN BOTULINUM TOXIN PRODUCTS

2.9. MARKET OPPORTUNITIES       

2.9.1. INCREASING AGING POPULATION      

2.9.2. RISE IN MEDICAL TOURISM       

3. LATIN AMERICA BOTULINUM TOXIN MARKET – BY TYPE       

3.1. TYPE A       

3.2. TYPE B       

4. LATIN AMERICA BOTULINUM TOXIN MARKET – BY APPLICATION   

4.1. COSMETIC APPLICATIONS      

4.1.1. GLABELLAR LINES

4.1.2. LATERAL CANTHAL LINES (CROW’S FEET)  

4.1.3. FOREHEAD LINES 

4.1.4. OTHER COSMETIC APPLICATIONS     

4.2. NON-COSMETIC APPLICATIONS        

4.2.1. DYSTONIA   

4.2.2. CHRONIC MIGRAINE        

4.2.3. OPHTHALMOLOGIC DISORDERS         

4.2.4. OTHER NON-COSMETIC APPLICATIONS       

5. LATIN AMERICA BOTULINUM TOXIN MARKET –  BY END-USER       

5.1. HOSPITALS           

5.2. CLINICS AND OTHERS  

6. LATIN AMERICA BOTULINUM TOXIN MARKET – REGIONAL OUTLOOK                               

6.1. COUNTRY ANALYSIS    

6.1.1. BRAZIL          

6.1.2. MEXICO        

6.1.3. REST OF LATIN AMERICA                      

7. COMPETITIVE LANDSCAPE 

7.1. ABBVIE INC           

7.2. EVOLUS INC

7.3. GALDERMA PHARMA SA (ACQUIRED BY EQT)      

7.4. HUGEL INC

7.5. IPSEN PHARMA   

7.6. MERZ PHARMA   

7.7. MEDYTOX INC

7.8. REVANCE THERAPEUTICS INC

7.9. US WORLDMEDS LLC    

8. METHODOLOGY & SCOPE    

8.1. RESEARCH SCOPE & DELIVERABLES        

8.2. SOURCES OF DATA       

8.3. RESEARCH METHODOLOGY   

List of Tables

TABLE 1: LATIN AMERICA BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 2: MARKET ATTRACTIVENESS MATRIX

TABLE 3: VENDOR SCORECARD

TABLE 4: LIST OF NEW PRODUCT LAUNCHES

TABLE 5: LATIN AMERICA BOTULINUM TOXIN MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 6: LATIN AMERICA BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 7: LATIN AMERICA BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

TABLE 8: LATIN AMERICA BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

TABLE 9: LATIN AMERICA BOTULINUM TOXIN MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 10: LATIN AMERICA BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1: PORTER’S FIVE FORCES ANALYSIS

FIGURE 2: LATIN AMERICA BOTULINUM TOXIN MARKET, BY TYPE, 2020 & 2028 (IN %)

FIGURE 3: LATIN AMERICA BOTULINUM TOXIN MARKET, BY TYPE A, 2021-2028 (IN $ MILLION)

FIGURE 4: LATIN AMERICA BOTULINUM TOXIN MARKET, BY TYPE B, 2021-2028 (IN $ MILLION)

FIGURE 5: LATIN AMERICA BOTULINUM TOXIN MARKET, BY APPLICATION, 2020 & 2028 (IN %)

FIGURE 6: LATIN AMERICA BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 7: LATIN AMERICA BOTULINUM TOXIN MARKET, BY GLABELLAR LINES, 2021-2028 (IN $ MILLION)

FIGURE 8: LATIN AMERICA BOTULINUM TOXIN MARKET, BY LATERAL CANTHAL LINES (CROW’S FEET), 2021-2028 (IN $ MILLION)

FIGURE 9: LATIN AMERICA BOTULINUM TOXIN MARKET, BY FOREHEAD LINES, 2021-2028 (IN $ MILLION)

FIGURE 10: LATIN AMERICA BOTULINUM TOXIN MARKET, BY OTHER COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 11: LATIN AMERICA BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 12: LATIN AMERICA BOTULINUM TOXIN MARKET, BY DYSTONIA, 2021-2028 (IN $ MILLION)

FIGURE 13: LATIN AMERICA BOTULINUM TOXIN MARKET, BY CHRONIC MIGRAINE, 2021-2028 (IN $ MILLION)

FIGURE 14: LATIN AMERICA BOTULINUM TOXIN MARKET, BY OPHTHALMOLOGIC DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 15: LATIN AMERICA BOTULINUM TOXIN MARKET, BY OTHER NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 16: LATIN AMERICA BOTULINUM TOXIN MARKET, BY END-USER, 2020 & 2028 (IN %)

FIGURE 17: LATIN AMERICA BOTULINUM TOXIN MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)

FIGURE 18: LATIN AMERICA BOTULINUM TOXIN MARKET, BY CLINICS AND OTHERS, 2021-2028 (IN $ MILLION)

FIGURE 19: LATIN AMERICA BOTULINUM TOXIN MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 20: BRAZIL BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 21: MEXICO BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 22: REST OF LATIN AMERICA BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;